임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

14건 표시

2상완료· Chronic Idiopathic Constipation
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
리드: SK바이오팜
상세 →NCT01989234
2상완료· Partial Epilepsy
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
리드: SK바이오팜
상세 →NCT01866111
2상완료· Chronic Constipation
A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation
리드: SK바이오팜
상세 →NCT01523184
2상완료· Painful Diabetic Neuropathy
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
리드: SK바이오팜
상세 →NCT01521598
2상완료· Partial Epilepsy
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
리드: SK바이오팜
상세 →NCT01397968
2상완료· Diabetic Neuropathies
An Efficacy and Safety Study of Carisbamate in the Treatment of Nerve Pain in Diabetics
리드: SK바이오팜
상세 →NCT00870454
2상완료· Epilepsy
Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
리드: SK바이오팜
상세 →NCT00616148
2상완료· Essential Tremor, Movement Disorders
A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor
리드: SK바이오팜
상세 →NCT00524056
2상완료· Diabetic Neuropathy, Painful
Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
리드: SK바이오팜
상세 →NCT00501202
2상완료· Postherpetic Neuralgia
An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).
리드: SK바이오팜
상세 →NCT00492323
2상완료· Epilepsy
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
리드: SK바이오팜
상세 →NCT00210522
2상완료· Refractory Epilepsy
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
리드: SK바이오팜
상세 →NCT00228969
2상완료· Epilepsy
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
리드: SK바이오팜
상세 →NCT00210652
2상완료· Migraine Headaches
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
리드: SK바이오팜
상세 →NCT00109083

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.